Please assess the completion status of the following clinical trial:

Trial Title: Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty (TKA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who meet the indications for use for Triathlon® Total Knee System using VERASENSE™~* Subject must be diagnosed with one or more of the following conditions~* osteoarthritis~* rheumatoid or other inflammatory arthritis~* post-traumatic arthritis~* Subject is likely to be available for all study visits~* Subject is able and willing to sign the informed consent and follow study procedures~Exclusion Criteria:~* Prior Total Knee Arthroplasty~* Avascular Necrosis~* Any knee surgery other than meniscectomy (can be arthroscopic or open)~* Ligament insufficiencies, prior surgeries such as anterior cruciate ligament (ACL) or PCL reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures~* Ipsilateral foot/ankle and hip arthritis~* Range of motion less than 90°, flexion contracture greater than 20°~* Subject has a mental condition that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease)~* Any subjects meeting any contraindication criteria as identified in the locally approved labeling for the device should be excluded from this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group A TKA without VERASENSE (Type: SHAM_COMPARATOR): Patients who undergo primary posterior cruciate ligament (PCL)-retaining or - sacrificing TKA without the use of VERASENSE to guide rotational alignment and balance.
- Group B TKA with VERASENSE (Type: ACTIVE_COMPARATOR): Patients who undergo primary PCL-retaining or - sacrificing TKA with the use of VERASENSE to guide rotational alignment and balance.

Based on this trial design, predict the completion outcome and termination type (if applicable).